Skip to main content

Table 2 Patient characteristics (metformin users versus nonmetformin users)

From: The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients

 

Nondiabetes mellitus (n = 49)

Diabetes mellitus met- (n = 43)

Diabetes mellitusmet+ (n = 49)

 

No. of patients

(%)

No. of patients

(%)

No. of patients

(%)

p value

Age

63.28 y

65.04 y

66.45 y

 

Alcohol

26

53.06

27

62.79

28

57.14

0.46

Betel Nut

25

51.02

24

55.81

27

55.10

0.45

Cigarette

28

57.14

31

72.09

33

67.35

0.54

T1

7

14.29

2

4.65

6

12.24

0.57

T2

13

26.53

12

27.91

16

32.65

0.11

T3

11

22.45

14

32.56

10

20.41

0.15

T4

18

36.73

14

32.56

17

34.69

0.54

N0

8

16.33

9

20.93

13

26.53

0.51

N1

9

18.37

5

11.63

6

12.24

0.07

N2

30

61.22

27

62.79

30

61.22

0.17

N3

2

4.08

2

4.65

2

4.08

0.33

M0

47

95.92

35

81.40

49

100.00

0.33

M1

2

4.08

8

18.60

0

0.00

0.06

Early stage

13

26.53

11

25.58

16

32.65

0.17

Late stage

36

73.47

32

74.42

33

67.35

0.51

  1. Met+, with metformin; met-, without metformin